Table: Santen Pharm -2025/26 parent results

SANTEN PHARMACEUTICAL

12/05/2026 07:33

May 12 (Reuters)- 
          Santen Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            171.78          188.10                                
                 (-8.7 pct)      (-3.7 pct)                              
  Operating         20.52           23.41                                
                 (-12.4 pct)     (-16.4 pct)                             
  Recurring         22.01           26.23                                
                 (-16.1 pct)     (-16.1 pct)                             
  Net               15.79           17.80                                
                 (-11.3 pct)     (-4.7 pct)                              
  EPS             48.18 yen       51.03 yen                              
  EPS Diluted     48.08 yen       50.89 yen                              
  Ann Div         38.00 yen       36.00 yen      42.00 yen               
  -Q2 Div         19.00 yen       17.00 yen      21.00 yen               
  -Q4 Div         19.00 yen       19.00 yen      21.00 yen               
  
  NOTE - Santen Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4536.T